FDA chief will testify at first meningitis hearing

(AP)—House lawmakers investigating a nationwide outbreak of deadly meningitis are asking the head of the Food and Drug Administration to testify at the first congressional hearing on the issue next week.

The Energy & Commerce Committee says FDA Commissioner Dr. Margaret Hamburg will appear before the committee on Nov. 14.

More than 400 people have been sickened by contaminated steroid shots distributed by New England Compounding Center, according to the Centers for Disease Control and Prevention. Twenty nine people have died.

Committee staffers say they have also invited Barry Cadden, co-founder of the compounding center, the specialty pharmacy linked to the . The committee has also invited James Coffey, director of the Massachusetts Board of Registration in Pharmacy. Staffers say they are awaiting replies from Cadden and Coffey.

0 shares

Related Stories

2nd firm agrees to temporary shutdown in outbreak

date Oct 10, 2012

(AP)—A Massachusetts company run by the same executives who operated a specialty pharmacy linked to a fatal meningitis outbreak has agreed to temporarily shut down for inspection by state and federal regulators.

US pharmacy linked to outbreak issues wide recall

date Oct 07, 2012

(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

Recommended for you

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.